(b) Pro Forma Financial Information.

The unaudited pro forma condensed combined financial information of the Company for the nine months ended September 30, 2012, for the year ended December 31, 2011, and as of September 30, 2012 giving effect to the acquisition of Medicis is attached hereto as Exhibit 99.3 and incorporated herein by reference.

(d) Exhibits.

The following exhibits are filed as part of this Report on Form 8-K:

2.1 Agreement and Plan of Merger, dated as of September 2, 2012, among Medicis

        Pharmaceutical Corporation, Valeant Pharmaceuticals International, Inc.,
        Valeant Pharmaceuticals International and Merlin Merger Sub, Inc.
        (incorporated by reference to Exhibit 2.1 of the Current Report on Form
        8-K (File No. 001-14956) filed on September 4, 2012).

99.3    Unaudited Pro Forma Condensed Combined Financial Statements and Related
        Notes.